Related Experiment Video
Updated: Jan 17, 2026

Modeling Charcot-Marie-Tooth Disease In Vitro by Transfecting Mouse Primary Motoneurons
Published on: January 7, 2019
Advances and Clues of Nutritional Adjuvant Therapy for Charcot-Marie-Tooth Disease
Yuqing Chen1, Junying Zhu1, Mingxin Wang1
1School of Public Health (Shenzhen), Shenzhen Campus of Sun Yat-sen University, Shenzhen, China.
Abstract:
Charcot-Marie-Tooth disease (CMT) is an inherited peripheral neuropathy with significant genetic heterogeneity and clinical variability. Currently, there are no specific drugs to cure the disease, and adjuvant therapies are used to alleviate the symptoms. By supporting the functions of nerves, bones, and muscles, as well as systemic metabolism, personalized intakes of energy and nutrients help slow down disease progression, delay CMT onset, relieve the suffering and pain of patients, and improve their quality of life. This review discusses the research progress on energy- and fat-manipulated diets (caloric restriction diet, ketogenic diet, and high-fat diet) and several nutrients (polyunsaturated fatty acids, phospholipids, copper, iron, zinc, selenium, vitamins A/D/E/C, and some vitamin Bs) in the treatment of CMT and related peripheral neuropathies, which is expected to encourage exploration on and application of healthy diets and nutritional intakes from the viewpoint of clinical nutrition to improve the symptoms of CMT.
More Related Videos
Related Concept Videos
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Alzheimer's Disease: Treatment
Atherosclerosis III: Management
Myasthenia Gravis: Overview and Treatment
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
Peripheral Artery Disease IV: Nursing Management
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...

